ACAMS Translates CAMS® into German and Announces Training Partnership with Frankfurt School of Finance & Management
The Association of Certified Anti-Money Laundering Specialists (ACAMS) is pleased to announce two strategic initiatives to support anti-financial crime professionals in Germany.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171128005211/en/
As part of its continued European expansion and ongoing commitment to developing ACAMS’ member services throughout the region, ACAMS’ globally recognized certified anti-money laundering specialist (CAMS®) accreditation program has been translated into German and will be launched at Frankfurt School Verlag’s Risiko Geldwäsche 2017 conference on November 29, 2017. CAMS® is widely regarded as a leader in the area of anti-money laundering certifications and recognized internationally by financial institutions, governments and regulators.
ACAMS and Frankfurt School of Finance & Management (Frankfurt School) are also pleased to announce the formation of a strategic training partnership to support AML professionals in Germany preparing for the CAMS® qualification. Frankfurt School’s inaugural CAMS® in German preparation training course will be held on March 21, 2018 with the first course graduates expected to take the examination at official testing centers across Germany in April.
“We are delighted to enter into partnership with such a prestigious business school as Frankfurt School Verlag and to include them in ACAMS’ network of international training partners,” said Angela Salter, ACAMS’ head of Europe. “We look forward to working closely with Frankfurt School to strengthen professionals’ international anti-money laundering expertise through CAMS® in German.”
“AML and financial crimes are global issues, and providing a globally recognized qualification, alongside local regulatory education, is very important to ACAMS,” added Salter. “We continue to invest in growing services for ACAMS members throughout Europe and know that organizations want their AML/CTF/CDD and sanctions professionals to have a guaranteed level of competence evidenced by a robust global qualification. The German-speaking, anti-financial crime community is a very important market for ACAMS and this widens the global appeal of CAMS®. ACAMS is proud to offer CAMS in a total of 11 languages.”
“As one of Europe’s leading international business schools specializing in finance and compliance, we’re delighted that the Frankfurt School will now offer training for the globally recognized CAMS® certification in German and English,” said Ms. Tina Vangelista, head of competence center governance and audit, professional and executive education, Frankfurt School. “This will sit alongside our established compliance and AML programming and confirms Frankfurt School’s commitment to delivering innovative and high-quality training that complements our well-established certification ‘Certified Compliance Professional’ (CCP).”
About Adtalem Global Education
The purpose of Adtalem Global Education is to empower students to achieve their goals, find success, and make inspiring contributions to our global community. Adtalem Global Education Inc. (NYSE: ATGE; member S&P MidCap 400 Index) is a leading global education provider and the parent organization of Adtalem Educacional do Brasil, American University of the Caribbean School of Medicine, Association of Certified Anti-Money Laundering Specialists, Becker Professional Education, Carrington College, Chamberlain University, DeVry University and its Keller Graduate School of Management, Ross University School of Medicine and Ross University School of Veterinary Medicine. For more information, please visit adtalem.com.
About the Association of Certified Anti-Money Laundering Specialists® (ACAMS®)
ACAMS is a member of Adtalem Global Education (NYSE: ATGE), a global education provider headquartered in the United States. The organization's purpose is to empower students to achieve their goals, find success and make inspiring contributions to our global community. ACAMS is the largest international membership organization dedicated to enhancing the knowledge and skills of anti-money laundering (AML) and financial crime professionals from a wide range of industries, with extensive resources designed to develop and sharpen the skills required for superior job performance and career advancement. Its CAMS certification is the most widely recognized AML certification among compliance professionals worldwide. Visit acams.org for more information. In addition to English, ACAMS also offers CAMS® in Arabic, Bahasa Indonesian, Chinese, Simplified Chinese, French, German, Japanese, Portuguese, Russian and Spanish.
About the Frankfurt School of Finance & Management
Frankfurt School of Finance & Management is a research-led business school accredited by EQUIS and AACSB International. Frankfurt School offers educational program covering financial, economic and management subjects, including Bachelor and Master degrees, various MBAs and a doctoral program, executive education, certified courses of study, open seminars and training courses for professionals, as well as seminars and workshops for those in vocational training. In their research, the members of Frankfurt School’s faculty explore topical aspects of business, management, banking and finance. Frankfurt School experts also manage advisory and training projects on financial matters in emerging markets and developing countries, especially on topics related to microfinance and renewable energy finance. Frankfurt School’s Master of Finance program is the only German-language Master degree in finance to appear in the current Financial Times ranking (at number 28 in June 2017). In the latest ranking of German-language higher-education program by German weekly business magazine Wirtschaftswoche, Frankfurt School ranked seventh in the Business Studies category. In addition to its campus in Frankfurt, Frankfurt School has study centers in Hamburg and Munich, as well as international offices in Ankara (Turkey), Beijing (China), Mumbai (India) and Nairobi (Kenya). It is a globally connected business school with over 125 partner universities. For more details see www.frankfurt-school.de .
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers18.2.2018 00:00 | Tiedote
Celgene Corporation (NASDAQ:CELG) today announced that data from the phase III RELIEF™ clinical trial of OTEZLA® (apremilast) in patients with active Behçet’s Disease with oral ulcers were presented in a late-breaking oral presentation at the 2018 American Academy of Dermatology (AAD) Annual Meeting. The results showed statistically significant reductions in oral ulcers with apremilast 30 mg twice daily (BID) versus placebo through week 12. OTEZLA (apremilast) is Celgene’s oral selective inhibitor of phosphodiesterase 4 (PDE4). Behçet’s Disease is a rare, chronic, multi-system inflammatory syndrome. Oral ulcers, the most common manifestation of Behçet’s Disease, can be disabling and have a substantial effect on quality of life. This study primarily evaluated the effect of apremilast on recurring oral ulcers in patients with active Behçet’s Disease who were previously treated with at least one topical or systemic medication. “Reducing oral ulcers, which are painful and can negatively im
CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study17.2.2018 11:00 | Tiedote
Twelve-month data from the Personalised Anti-TNF therapy in Crohn’s disease Study (PANTS) was presented at the 13th Congress of the European Crohn’s and Colitis Organisation (ECCO). The results indicate that the clinical effectiveness, safety and immunogenicity of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) in patients with Crohn’s disease (CD) is comparable to those treated with reference infliximab as well as those treated with adalimumab.1 The UK-wide, three-year prospective observational study investigated primary non-response (PNR), loss of response (LOR) and adverse drug reactions (ADR) to infliximab (reference infliximab and CT-P13) and adalimumab in 1610 CD patients. The data show comparable efficacy between CT-P13, reference infliximab and adalimumab in relation to PNR, LOR and ADR rates. In addition, at week 54, the remission rate was 39.7%, 39.0% and 32.7% for reference infliximab, CT-P13 and adalimumab treated patients, respectively.1 The PANTS study investigates
Avanti Communications HYLAS 4 Satellite Arrives in French Guiana16.2.2018 21:26 | Tiedote
Avanti Communications Group plc (“Avanti”), a leading provider of satellite data communications services in Europe, the Middle East and Africa (“EMEA”), announces its HYLAS 4 satellite has arrived safely in French Guiana ahead of its March 2018 launch. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005586/en/ Avanti Communications HYLAS 4 Satellite Arrives in French Guiana (Photo: Business Wire) The spacecraft, built by Orbital ATK was packed and shipped at their Satellite Manufacturing Facility in Dulles, Virginia, United States and flown to French Guiana, where it was unloaded and will be taken to the Arianespace launch facilities in Kourou. HYLAS 4 uses the latest High Throughput Satellite technology, doubling Avanti's Ka-band capacity across EMEA. The latest addition to Avanti's HYLAS fleet will provide: Backhaul services for mobile network operators Wholesale broadband for ISPs Connectivity for governments (civil a
General Cable Corporation Stockholders Approve Acquisition By Prysmian Group16.2.2018 20:05 | Tiedote
General Cable Corporation (NYSE: BGC) today announced the voting results from the Company’s special meeting of stockholders held this morning. Stockholders of General Cable approved the Company’s previously announced acquisition by Prysmian Group (BIT: PRY) for $30.00 per share in cash. A total of 38,140,754 shares, representing approximately 75.34% of the total number of shares of common stock outstanding and approximately 99% of the total votes cast, were voted in favor of the merger. Subject to regulatory approvals and other customary closing conditions, the transaction is expected to close by the third quarter of 2018. About General Cable General Cable (NYSE:BGC), with headquarters in Highland Heights, Kentucky, is a global leader in the development, design, manufacture, marketing and distribution of aluminum, copper and fiber optic wire and cable products for the energy, communications, automotive, industrial, construction and specialty segments. General Cable is one of the larges
Systemic Sclerosis World Congress:Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease16.2.2018 12:03 | Tiedote
Boehringer Ingelheim today unveils a new phase of 'More Than Scleroderma: The Inside Story', and launches the new patient website www.morethanscleroderma.com. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005188/en/ Anna, 36, living with scleroderma (Photo: Business Wire) The global initiative highlights the importance of understanding the ‘inside story’ of each individual living with scleroderma, also known as systemic sclerosis. To coincide with the Systemic Sclerosis World Congress in Bordeaux, 15-17 February 2018, new and truly inspiring patient stories are revealed, reflecting the real-life, diverse and very moving journeys of people living with scleroderma across the world. The campaign will also be launched in the U.S. The new website www.morethanscleroderma.com features a powerful collection of photographs and video stories of people living with scleroderma across the world, revealing the life-changing impact o
Philip Morris International Recognized as a Global Top Employer for the Second Year in a Row16.2.2018 11:00 | Tiedote
Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today is recognized for the second year in a row as a Global Top Employer. This year’s certification from the Top Employer Institute is awarded to PMI teams in 44 countries, a testament to the company’s consistency and excellence in offering an enriching and dynamic work environment, and exceptional development opportunities for employees across the globe. PMI has been recognized by the Top Employer Institute for six consecutive years. This year, PMI was awarded with five regional certifications in Europe, the Middle East, Africa and, for the first time, in North America and Latin America. Additionally, Indonesia was the first PMI affiliate to be certified in Asia. “It is a proud moment for all of us at PMI,” said Charles Bendotti, PMI Senior Vice President, People and Culture. “Our success as a company relies on the men and women who come to work every day with a passion to achieve, and a willingness to learn, grow, and
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme